Literature DB >> 23772832

Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology.

Giulio Fortuna1, Francina Lozada-Nur, Annamaria Pollio, Massimo Aria, Rodrigo Cepeda-Valdes, Matt Peter Marinkovich, Anna L Bruckner, Julio Cesar Salas-Alanís.   

Abstract

BACKGROUND: The oral mucosa in patients with epidermolysis bullosa (EB) can be affected with different lesions and degrees of severity. However, patterns of oral lesions in distinct types of EB are still unclear.
OBJECTIVES: The purpose of this study was to determine the frequency and distribution of four types of lesions (erythema, erosion, atrophy, and blister) for each oral site and to calculate the interobserver reliability for each type of lesion in each site.
METHODS: Ninety-two patients with different EB types were assessed independently by an oral medicine specialist and a dermatologist. The degree of agreement was calculated by the intraclass correlation coefficient (ICC).
RESULTS: The most affected oral site was the tongue, with the most frequent lesion being erythema and atrophy [54(58.7%) patients] for the oral medicine specialist and erosion [54(58.7%) patients] for the dermatologist. Patients with recessive dystrophic EB-severe generalized (RDEB-sev gen) showed the highest mean of sites involved by each lesion for both oral medicine and dermatology. The interobserver reliability on the total of lesions was excellent on only 3 sites: lower lip (ICC: 0.89; 95%CI:0.83-0.92), hard palate (ICC:0.85; 95%CI:0.72-0.91), and tongue (ICC:0.89; 95%CI:0.84-0.92), whereas the interobserver reliability calculated for each single oral lesion showed a lower agreement.
CONCLUSION: Total distribution of sites involved by four types of lesions was higher in RDEB-sev gen than in the rest of EB types, with a predominance of erythema followed by erosion. The agreement on the type of lesion was found to be poor-moderate for many oral sites.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bullous lesions; oral mucosa

Mesh:

Year:  2013        PMID: 23772832     DOI: 10.1111/jop.12094

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Dental and Anaesthetic Challenges in a Patient with Dystrophic Epidermolysis Bullosa.

Authors:  Ali Al-Abadi; Salah A Al-Azri; Abdulaziz Bakathir; Yusra Al-Riyami
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

2.  Diagnosis of Lingual Atrophic Conditions: Associations with Local and Systemic Factors. A Descriptive Review.

Authors:  M Erriu; F M G Pili; S Cadoni; V Garau
Journal:  Open Dent J       Date:  2016-11-16

3.  Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen.

Authors:  Katarzyna Osipowicz; Piotr Wychowanski; Pawel Nieckula; Sara Shamsa; Katarzyna Wertheim-Tysarowska; Katarzyna Wozniak; Cezary Kowalewski
Journal:  Postepy Dermatol Alergol       Date:  2020-07-14       Impact factor: 1.837

4.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11

5.  Pain in Patients with Dystrophic Epidermolysis Bullosa: Association with Anxiety and Depression.

Authors:  Giulio Fortuna; Massimo Aria; Rodrigo Cepeda-Valdes; Maria Guadalupe Moreno Trevino; Julio Cesar Salas-Alanís
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.